Eiko Lifesciences Ltd — Others, 29-07-2025: AGM/EGM

Eiko LifeSciences has called its 48th Annual General Meeting for shareholder approvals. The agenda includes adopting the audited full-year financial results for March 31, 2025. Key proposals involve increasing the authorized share capital from 14 Cr to 20 Cr, and approving material related party transactions with values up to 20 Cr, including some personnel remunerations. Shareholders will also vote on appointing a secretarial auditor and Mr. Sumukh Prabhakar Vartak as a Whole Time Director (0.06 Cr annually). Re-appointment of Mr. Laxmikant Kabra and independent directors Ms. Kajal Kothari and Mr. Rajkumar Baheti for new terms is also on the agenda.